BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32414455)

  • 1. A review on fucoidan antitumor strategies: From a biological active agent to a structural component of fucoidan-based systems.
    Oliveira C; Neves NM; Reis RL; Martins A; Silva TH
    Carbohydr Polym; 2020 Jul; 239():116131. PubMed ID: 32414455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer effects of fucoidan.
    Senthilkumar K; Kim SK
    Adv Food Nutr Res; 2014; 72():195-213. PubMed ID: 25081084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms.
    van Weelden G; Bobiński M; Okła K; van Weelden WJ; Romano A; Pijnenborg JMA
    Mar Drugs; 2019 Jan; 17(1):. PubMed ID: 30621045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer and antitumor potential of fucoidan and fucoxanthin, two main metabolites isolated from brown algae.
    Zorofchian Moghadamtousi S; Karimian H; Khanabdali R; Razavi M; Firoozinia M; Zandi K; Abdul Kadir H
    ScientificWorldJournal; 2014; 2014():768323. PubMed ID: 24526922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles.
    Jin JO; Chauhan PS; Arukha AP; Chavda V; Dubey A; Yadav D
    Mar Drugs; 2021 May; 19(5):. PubMed ID: 34068561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fucoidans from brown seaweeds Sargassum hornery, Eclonia cava, Costaria costata: structural characteristics and anticancer activity.
    Ermakova S; Sokolova R; Kim SM; Um BH; Isakov V; Zvyagintseva T
    Appl Biochem Biotechnol; 2011 Jul; 164(6):841-50. PubMed ID: 21302149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fucoidan, a brown seaweed polysaccharide in nanodrug delivery.
    George A; Shrivastav PS
    Drug Deliv Transl Res; 2023 Oct; 13(10):2427-2446. PubMed ID: 37010790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucoidan as a marine anticancer agent in preclinical development.
    Kwak JY
    Mar Drugs; 2014 Jan; 12(2):851-70. PubMed ID: 24477286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fucoidan: Biological Activity in Liver Diseases.
    Li J; Guo C; Wu J
    Am J Chin Med; 2020; 48(7):1617-1632. PubMed ID: 33148007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of fucoidan from Sargassum polycystum brown algae: Structural characterization, in vitro antioxidant and anticancer activity.
    Palanisamy S; Vinosha M; Marudhupandi T; Rajasekar P; Prabhu NM
    Int J Biol Macromol; 2017 Sep; 102():405-412. PubMed ID: 28400184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fucoidan fraction from Ascophyllum nodosum.
    Marais MF; Joseleau JP
    Carbohydr Res; 2001 Nov; 336(2):155-9. PubMed ID: 11689185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparison of structure and anticancer activity in vitro of polysaccharides from brown algae Alaria marginata and A. angusta.
    Usoltseva Menshova RV; Anastyuk SD; Shevchenko NM; Zvyagintseva TN; Ermakova SP
    Carbohydr Polym; 2016 Nov; 153():258-265. PubMed ID: 27561495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcritical water extraction as an efficient technique to isolate biologically-active fucoidans from Nizamuddinia zanardinii.
    Alboofetileh M; Rezaei M; Tabarsa M; You S; Mariatti F; Cravotto G
    Int J Biol Macromol; 2019 May; 128():244-253. PubMed ID: 30684576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seaweeds in the Oncology Arena: Anti-Cancer Potential of Fucoidan as a Drug-A Review.
    Jin JO; Yadav D; Madhwani K; Puranik N; Chavda V; Song M
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway.
    Rui X; Pan HF; Shao SL; Xu XM
    BMC Complement Altern Med; 2017 Aug; 17(1):378. PubMed ID: 28764703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis.
    Klettner A
    Mar Drugs; 2016 Feb; 14(2):. PubMed ID: 26848666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of brown-algae polysaccharides for the development of anticancer agents: An update on anticancer effects reported for fucoidan and laminaran.
    Sanjeewa KKA; Lee JS; Kim WS; Jeon YJ
    Carbohydr Polym; 2017 Dec; 177():451-459. PubMed ID: 28962791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel fucoidan based bioactive targeted nanoparticles from Undaria Pinnatifida for treatment of pancreatic cancer.
    Etman SM; Abdallah OY; Elnaggar YSR
    Int J Biol Macromol; 2020 Feb; 145():390-401. PubMed ID: 31881303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Targets and Related Biologic Activities of Fucoidan: A Review.
    Lin Z; Tan X; Zhang Y; Li F; Luo P; Liu H
    Mar Drugs; 2020 Jul; 18(8):. PubMed ID: 32707775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfated galactofucan from Lobophora variegata: anticoagulant and anti-inflammatory properties.
    Medeiros VP; Queiroz KC; Cardoso ML; Monteiro GR; Oliveira FW; Chavante SF; Guimaraes LA; Rocha HA; Leite EL
    Biochemistry (Mosc); 2008 Sep; 73(9):1018-24. PubMed ID: 18976219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.